Scientists find the gene that drives T-cell exhaustion, revealing new strategy to improve immune responses

Дата публикации: 23-09-2026 23:00:07

Immunotherapy, which uses a patient's immune system to treat disease, has increased survival for some adults and children with cancer. However, it has had limited success against many pediatric solid tumors, in part because T cells can become functionally impaired or "exhausted." St. Jude Children's Research Hospital scientists published results in Nature showing that the gene ZMYND8 is a major regulator of CD8+ T-cell exhaustion. The results also showed that removing the gene improves antitumor and antiviral responses on its own and may have a synergistic effect with immunotherapy.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Cancer biologists bring in the B-cell reinforcements for immunotherapy	0	8.93	17-09-2026
2	Activated donor immune cells may prevent severe complication after allogeneic stem cell transplantation	0	8.94	20-09-2026
3	Wiskott-Aldrich syndrome: Long-term results of gene therapy developed	0	13.28	24-09-2026
4	Immune cells reveal widespread SMN protein loss in spinal muscular atrophy	0	6.31	24-09-2026
5	Metabolic activity of gut bacteria can either promote or inhibit function of CAR T cells in cancer therapy	0	6.96	28-09-2026
6	Newly discovered inflammatory cell signaling could open the door to autoimmune disease treatments	0	10.81	23-09-2026
7	Computer-designed T-cell receptors boost attacks on cancer and viral targets in early tests	0	11.68	23-09-2026
8	A blood-based approach could enable personalized immunotherapy without the need for a tumor biopsy	0	10.91	29-09-2026
9	Boosted Bacille Calmette-Guérin vaccine strategy significantly reduces tuberculosis relapse, scientists find	0	9.58	17-09-2026
10	Teaching the immune system to control HIV	0	7.4	17-09-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.6. Источник: medicalxpress.com.